Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 953.26 million compared to CNY 1,086.79 million a year ago. Revenue was CNY 953.98 million compared to CNY 1,087.67 million a year ago.

Net income was CNY 80.87 million compared to CNY 111.52 million a year ago. Basic earnings per share from continuing operations was CNY 0.3489 compared to CNY 0.4809 a year ago. Diluted earnings per share from continuing operations was CNY 0.3307 compared to CNY 0.4579 a year ago.